2026 IECMD 2025 - 4 articles
The 2nd International Electronic Conference on Medicine
Online| 11–13 November 2025
Volume Editors:
Alberto Ouro, Health Research Institute of Santiago de Compostela, Spain;
Clinical University Hospital (CHUS), SERGAS, Santiago de Compostela, Spain
Allison B. Reiss, New York University Long Island School of Medicine, Mineola, New York, USA
The coronavirus disease 2019 (COVID-19) pandemic has disrupted both health and occupational functioning in participants with multiple sclerosis (PwMS). This review synthesizes evidence from 55 studies (30,830 PwMS) on psychological, social, and work-...
Background. Cannabis and cannabinoids have been investigated for their potential therapeutic effects in Parkinson’s disease, but clinical research findings remain scant and inconsistent. This study provides a systematic overview of peer-reviewe...
Background: Alzheimer’s disease (AD) and mild cognitive impairment (MCI) are traditionally defined by progressive cognitive decline, yet neuropsychiatric symptoms (NPS), including depression, apathy, anxiety, irritability, and sleep disturbance...
Sweetener consumption has increased considerably in recent decades, driven by the growing demand from consumers of low-calorie products for weight control and, especially, from diabetic patients who require safe sweetener alternatives without affecti...
